Home
Conditions
Histiocytosis

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

406 public trials 82 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

NCT00059995

Conditions: Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +19 more
Locations: Mayo Clinic Cancer Center Rochester, Minnesota, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States

Piedmont Hospital Atlanta, Georgia, United States

Northside Hospital Cancer Center Atlanta, Georgia, United States

Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States

View all 82 locations

View Trial Details

Completed

Study of @neWorld: A Virtual Community for Children With Cancer

NCT00070421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations: Leap of Faith Technologies, Incorporated Crystal Lake, Illinois, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine

NCT00975689

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

NCT00126477

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

NCT00521430

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +76 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

NCT00003408

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +122 more
Locations: Midwestern Regional Medical Center Zion, Illinois, United States

View Trial Details

Completed

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

NCT00569283

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +110 more
Locations: Korea Research Institute of Bioscience and Biotechnology Dajeon, South Korea

Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Histiocytosis

Histiocytosis trial results

Related conditions